Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Respir Med. 2016 Jul 28;118:88–95. doi: 10.1016/j.rmed.2016.07.016

Table 1.

Patient Characteristics

All
n=200
IPF
n=134
Not IPF
n=66
p**

Age (y), Mean (SD) 64.5 (8.5) 65.2 (7.2) 63.1 (10.4) 0.14

Male, No. (%) 104 (52.0) 73 (54.5) 31 (47.0) 0.32

Race, No. (%)
 Black 7 (3.5) 6 (4.5) 1 (1.5) 0.43
 White 184 (92.0) 120 (89.6) 64 (97.0) 0.07
 Other 9 (4.5) 8 (6.0) 1 (1.5) 0.28

Ever-Smoker, No. (%)* 106 (53.0) 67 (51.9) 39 (59.1) 0.34

FVC %-predicted, Mean (SD)* 69.2 (15.4) 68.1 (15.2) 71.4 (15.9) 0.16

DLCO %-predicted, Mean (SD)* 57.5 (17.2) 55.4 (16.5) 62.1 (18.0) 0.02

Primary HRCT Pattern, No. (%)
 IPF/UIP 12 (6.0) 10 (7.5) 2 (3.0) 0.34
 NSIP 135 (67.5) 94 (70.2) 41 (62.1) 0.25
 Chronic HP 18 (9.0) 10 (7.5) 8 (12.1) 0.28
 Uncharacterized Fibrosis 35 (17.5) 20 (14.9) 15 (22.7) 0.17

Final Clinical Diagnosis, No. (%)
 Idiopathic Pulmonary Fibrosis 134 (67.0)
 Nonspecific Interstitial Pneumonitis 18 (9.0)
 Hypersensitivity Pneumonia 33 (16.5)
 Uncharacterized Fibrosis 10 (5.0)
 Desquamative Interstitial Pneumonia 2 (1.0)
 Cryptogenic Organizing Pneumonia 3 (1.5)
*

No. of subjects with missing data: 5 smoking status (patient non-reporting on questionnaire), 3 FVC% (test not performed or reported by referring center), and 23 DLCO% (test not performed or reported by referring center).

**

p-values compare IPF to not IPF patients.

Abbreviations: FVC forced vital capacity, DLCO diffusing capacity of the lung for carbon monoxide, HRCT high resolution computed tomography, IPF idiopathic pulmonary fibrosis, UIP usual interstitial pneumonia, NSIP nonspecific interstitial pneumonia, HP hypersensitivity pneumonia.